Contributions of RedirectRini

Contributions by RedirectRini, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,088 edits includes activity predating the current log.

1. 16:17, 21 Apr 2026 (diff | hist) Third-party testing 7,489 ±0 state the method the reporting service uses, since it is not the only one available
2. 16:10, 6 Mar 2026 (diff | hist) List of GLP-1 receptor agonists 3,862 ±0 m expand the comparison so all four subjects have the same rows
3. 16:41, 8 Jul 2025 (diff | hist) Patent expiry and biosimilars 3,580 ±0 fix the anchor on an internal link
4. 19:09, 10 Apr 2025 (diff | hist) Cold-chain freight 3,699 ±0 m expand §How much it matters for a lyophilised peptide
5. 06:51, 2 Feb 2025 (diff | hist) Deamidation 3,531 +34 m add the figure for the chromatogram and caption its axes
6. 00:44, 30 Dec 2024 (diff | hist) Weight regain after discontinuation 3,570 +34 add the medical-disclaimer cross-link
7. 14:14, 29 Nov 2024 (diff | hist) List of GLP-1 receptor agonists 2,606 ±0 reconcile the list against the category; two articles were missing
8. 03:15, 28 Nov 2024 (diff | hist) Janoshik Analytical 3,638 ±0 British spelling per PP:MOS
9. 03:25, 29 Oct 2024 (diff | hist) Triple agonist 2,546 +503 add the excipient list from the labelling
10. 13:00, 25 Oct 2024 (diff | hist) Amylin receptor agonist 2,228 +627 expand §Analytical notes
11. 05:15, 23 Oct 2024 (diff | hist) Peptide aggregation 2,241 ±0 convert the method-comparison paragraph to a table